Learn how to reduce duplicate references in your pharmacovigilance literature monitoring process

Download the whitepaper today

Fill out the form on the right to download the whitepaper  

Around 30% of pharmacovigilance literature review references are duplicates. This costs pharmaceuticals time and money.

Our whitepaper Finding the One can help you do something about it. Fill out the form to get the whitepaper and you'll learn:

Why duplicates are one of the biggest sources of inefficiency in your medical literature monitoring process

The regulatory and compliance risks that can be caused by processing too many duplicate references

The best practices drug safety teams should follow to reduce duplicate literature references


For security purposes and protection of customer data, we have disabled the ability to edit your email address within this form.

Not  ? Please clear the form before submitting.

Privacy regulations require that we get your consent to continue to collect, store and use the personal information submitted for account creation or collected while using our services.

*  I consent to the collection and use of my personal information consistent with the Privacy Policy. I acknowledge that use of the service is subject to the Terms & Conditions.